Cargando…
Modeling Type 1 Diabetes In Vitro Using Human Pluripotent Stem Cells
Understanding the root causes of autoimmune diseases is hampered by the inability to access relevant human tissues and identify the time of disease onset. To examine the interaction of immune cells and their cellular targets in type 1 diabetes, we differentiated human induced pluripotent stem cells...
Autores principales: | Leite, Nayara C., Sintov, Elad, Meissner, Torsten B., Brehm, Michael A., Greiner, Dale L., Harlan, David M., Melton, Douglas A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cell Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359783/ https://www.ncbi.nlm.nih.gov/pubmed/32668238 http://dx.doi.org/10.1016/j.celrep.2020.107894 |
Ejemplares similares
-
Genetic manipulation of stress pathways can protect stem-cell-derived islets from apoptosis in vitro
por: Leite, Nayara C., et al.
Publicado: (2022) -
Engineering human stem cell-derived islets to evade immune rejection and promote localized immune tolerance
por: Gerace, Dario, et al.
Publicado: (2023) -
An improved ScoreCard to assess the differentiation potential of human pluripotent stem cells
por: Tsankov, Alexander M., et al.
Publicado: (2015) -
Whole-genome CRISPR screening identifies genetic manipulations to reduce immune rejection of stem cell-derived islets
por: Sintov, Elad, et al.
Publicado: (2022) -
Alloimmune Responses of Humanized Mice to Human Pluripotent Stem Cell Therapeutics
por: Kooreman, Nigel G., et al.
Publicado: (2017)